| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allogeneic transplantation for high-risk chronic lymphocytic leukemia—a summary of a 16-year experience
|
Helbig, Grzegorz
|
|
2019
|
98 |
6 |
p. 1477-1483
|
article
|
| 2 |
A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots
|
Kárai, Bettina
|
|
2019
|
98 |
6 |
p. 1413-1420
|
article
|
| 3 |
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
|
Diamantopoulos, Panagiotis T.
|
|
2019
|
98 |
6 |
p. 1383-1392
|
article
|
| 4 |
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients
|
Gaudio, Francesco
|
|
2019
|
98 |
6 |
p. 1449-1455
|
article
|
| 5 |
Cardiac complications and iron overload in beta thalassemia major patients—a systematic review and meta-analysis
|
Koohi, F.
|
|
2019
|
98 |
6 |
p. 1323-1331
|
article
|
| 6 |
Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience
|
Metafuni, Elisabetta
|
|
2018
|
98 |
6 |
p. 1495-1497
|
article
|
| 7 |
Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm
|
Yang, Chunli
|
|
|
98 |
6 |
p. 1525-1527
|
article
|
| 8 |
Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm
|
Yang, Chunli
|
|
2019
|
98 |
6 |
p. 1525-1527
|
article
|
| 9 |
Diffuse large B cell lymphoma and schistosomiasis: a rare simultaneous occurrence
|
Zanelli, Magda
|
|
2018
|
98 |
6 |
p. 1511-1512
|
article
|
| 10 |
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome
|
Hadjiaggelidou, Christina
|
|
2019
|
98 |
6 |
p. 1457-1466
|
article
|
| 11 |
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma
|
Yamasaki, Satoshi
|
|
2018
|
98 |
6 |
p. 1521-1523
|
article
|
| 12 |
Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60–69 years with myelodysplastic syndrome
|
Itonaga, Hidehiro
|
|
2019
|
98 |
6 |
p. 1367-1381
|
article
|
| 13 |
Inhibitor eradication in refractory acquired hemophilia with lenalidomide
|
Pfrepper, C.
|
|
2019
|
98 |
6 |
p. 1533-1535
|
article
|
| 14 |
Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy
|
Yokoo, Masako
|
|
2018
|
98 |
6 |
p. 1501-1503
|
article
|
| 15 |
Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma
|
Serrao, Alessandra
|
|
2018
|
98 |
6 |
p. 1505-1506
|
article
|
| 16 |
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)
|
Kessler, Torsten
|
|
2019
|
98 |
6 |
p. 1393-1401
|
article
|
| 17 |
Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis
|
Demuynck, T.
|
|
2019
|
98 |
6 |
p. 1421-1426
|
article
|
| 18 |
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study
|
Trudel, Sabrina
|
|
2019
|
98 |
6 |
p. 1441-1447
|
article
|
| 19 |
Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network
|
Ricchi, Paolo
|
|
2019
|
98 |
6 |
p. 1333-1339
|
article
|
| 20 |
Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?
|
Haefliger, Simon
|
|
2018
|
98 |
6 |
p. 1513-1516
|
article
|
| 21 |
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia
|
Pejsa, Vlatko
|
|
2018
|
98 |
6 |
p. 1509-1510
|
article
|
| 22 |
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome
|
Trakada, Georgia
|
|
2019
|
98 |
6 |
p. 1427-1434
|
article
|
| 23 |
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study
|
Soltermann, Yves
|
|
2019
|
98 |
6 |
p. 1485-1493
|
article
|
| 24 |
Retrospective analysis of thiamine deficiency in allogeneic stem cell transplant patients
|
Levavi, Hannah
|
|
2018
|
98 |
6 |
p. 1499-1500
|
article
|
| 25 |
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study
|
Jullien, Maxime
|
|
2019
|
98 |
6 |
p. 1435-1440
|
article
|
| 26 |
Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma
|
Lamm, Wolfgang
|
|
2018
|
98 |
6 |
p. 1519-1520
|
article
|
| 27 |
Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low–middle-income country
|
Lins, Mecneide Mendes
|
|
2019
|
98 |
6 |
p. 1403-1411
|
article
|
| 28 |
Synchronous follicular non-Hodgkin’s lymphoma and hairy cell leukaemia: a case report
|
McDonald, Laura
|
|
2018
|
98 |
6 |
p. 1517-1518
|
article
|
| 29 |
The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage
|
Zeng, Linshu
|
|
2019
|
98 |
6 |
p. 1467-1476
|
article
|
| 30 |
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study
|
Ames, N. J.
|
|
2019
|
98 |
6 |
p. 1351-1365
|
article
|
| 31 |
Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis
|
Martino, Giovanni
|
|
2018
|
98 |
6 |
p. 1507-1508
|
article
|
| 32 |
Use of eltrombopag in aplastic anemia in Europe
|
Ecsedi, Matyas
|
|
2019
|
98 |
6 |
p. 1341-1350
|
article
|
| 33 |
Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation
|
Boasman, Kristian
|
|
2019
|
98 |
6 |
p. 1529-1531
|
article
|
Journal description